Biocompatible membranes in acute renal failure

Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells.

Clinical nephrology·2004

Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.

Clinical nephrology·2003

Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients.

Kidney international·2000

Dialysis time: what you prescribe is what you get? (WYPIWYG).

EDTNA/ERCA journal (English ed.)·1999

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.

Clinical nephrology·1997

Continuous administration of intravenous iron during haemodialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1997

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Triple-Shielded Microneedle Patch: A Synergistic Approach to Combat Infection, Oxidation and Inflammation in Wound Healing.

Small (Weinheim an der Bergstrasse, Germany)·2026

Short-Term Outcomes of Augmentation Urethroplasty in Recurrent Urethral Stricture Following Repeated Failed Optical Internal Urethrotomy: A Prospective Study.

Cureus·2026

Effects of Black Soldier Fly Larval (Hermetia illucens) Replacement Diet on Hybrid Grouper (Epinephelus lanceolatus ♂ × E. fuscoguttatus ♀) Through a Multipronged Nutrigenomic Analysis.

Aquaculture nutrition·2026

Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review.

Frontiers in cell and developmental biology·2026

Immunomodulatory effects of nematode-microbiota interactions in cancer therapy.

Frontiers in immunology·2026

Toxoplasma gondii Microneme Protein 3 (TgMIC3): Computational Probing for Improved Vaccine Design.

Iranian journal of parasitology·2026

Related Experiment Videos

Biocompatible membranes in acute renal failure

Related Concept Videos

Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells.

Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.

Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients.

Dialysis time: what you prescribe is what you get? (WYPIWYG).

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.

Continuous administration of intravenous iron during haemodialysis.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Triple-Shielded Microneedle Patch: A Synergistic Approach to Combat Infection, Oxidation and Inflammation in Wound Healing.

Short-Term Outcomes of Augmentation Urethroplasty in Recurrent Urethral Stricture Following Repeated Failed Optical Internal Urethrotomy: A Prospective Study.

Effects of Black Soldier Fly Larval (Hermetia illucens) Replacement Diet on Hybrid Grouper (Epinephelus lanceolatus ♂ × E. fuscoguttatus ♀) Through a Multipronged Nutrigenomic Analysis.

Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review.

Immunomodulatory effects of nematode-microbiota interactions in cancer therapy.

Toxoplasma gondii Microneme Protein 3 (TgMIC3): Computational Probing for Improved Vaccine Design.

Related Experiment Videos

Biocompatible membranes in acute renal failure

Related Concept Videos

Related Articles